DUBLIN, Sept. 29, 2015 /PRNewswire/ --
Research and Markets (http://www.researchandmarkets.com/research/4hrdzr/global_gene) has announced the addition of the "Global Gene Therapy Market Outlook 2020" report to their offering.
According to this new research report Global Gene Therapy Market Outlook 2020, a major focus has been on the ongoing clinical trials for the development of innovative products. In this context, the study provides a comprehensive overview of various aspects of the clinical trials in the gene therapy market, such as phases, geographies, vector types, etc.
As indicated by the new estimation carried out in our most recent study, the global gene therapy industry can possibly turn into a multi-million dollar industry by the end of 2020, as new products, particularly those in the advanced stage of clinical studies or with pending approvals, may enter the market to boost the growth.
The gene therapy market has very few marketed products. The market is majorly in the research phase from which most of its revenue is generated. The report also provides the sales of major marketed gene therapy products and the list of the products in clinical/pre-clinical research along with their clinical phases.
The companies operating in the gene therapy market are also receiving various funding, grants, and investment from government bodies and venture capitalist firms, which are aiding them to develop new products. The study highlights the applications for which the investments have been received.
Primarily, the gene therapy market is dominated by oncology applications with several companies and academic institutions focusing on novel and difficult to treat' cancers. Other therapeutic areas seeking developments in gene therapy include monogenic diseases, cardiovascular diseases, infectious diseases, inherited blindness and neurological diseases. The report provides the market analysis of key therapeutic areas along with the forecast till 2020.
North America continues to have the maximum number of clinical trials in the gene therapy segment. This is a major reason for the dominant position of North America in the gene therapy market. Based on the geography, the market is divided into four regions, namely, North America, Europe, Asia and Rest of the World. The report provides the market for each of the geography, along with its forecast till 2020.
Key Topics Covered:
1. Analyst View
2. Research Methodology
3. Gene Therapy - An Introduction
4. Industry Overview
5. Clinical Trial Assessment & Pipeline Analysis
6. Gene Therapy Market - Regulatory Landscape & Reimbursement Scenario
7. Marketed Gene Therapies
8. Global Gene Therapy Market
9. Gene Therapy Market by Application
10. Global Gene Therapy Market Size by Geography
11. Competitive Landscape
12. Key Players Analysis (Business Description, Clinical Pipeline, Recent Developments, Strengths & Weaknesses)
- Advantagene Inc.
- Bluebird Bio
- Human Stem Cells Institute
- Oxford BioMedica Plc
- Shanghai Sunway Biotech Co. Ltd.
- Sibiono GeneTech Co. Ltd.
- Spark Therapeutics, LLC
- UniQure N.V.
- Vical Inc.
- ViroMed Co. Ltd. dba VM BioPharma
For more information visit http://www.researchandmarkets.com/research/4hrdzr/global_gene
Media Contact: Laura Wood , +353-1-481-1716, email@example.com
SOURCE Research and Markets